In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
Background: Latent tuberculosis has been associated with the persistence of dormant Mycobacterium tuberculosis in the organism of infected individuals, who are reservoirs of the bacilli and the source for spreading the disease in the community. New active anti-TB drugs exerting their metabolic actio...
| Autores principales: | , , |
|---|---|
| Formato: | info:eu-repo/semantics/article |
| Lenguaje: | Inglés |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/1961 http://www.elsevier.es/en-revista-revista-argentina-microbiologia-372-resumen-in-vitro-anti-tuberculosis-activity-azole-S0325754117300895 http://dx.doi.org/10.1016/j.ram.2017.02.008 |
Ejemplares similares: In vitro anti-tuberculosis activity of azole drugs against Mycobacterium tuberculosis clinical isolates
- Fitness of drug resistant Mycobacterium tuberculosis and the impact on the transmission among household contacts
- Surveillance and characterization of drug‑resistant mycobacterium tuberculosis isolated in a reference hospital from Argentina during 8 years’ period
- A phenotypic characterization of two isolates of a multidrug-resistant outbreak strain of mycobacterium tuberculosis with opposite epidemiological fitness
- Mycobacterium tuberculosis infection in a free‑ranging urban dog from Argentina
- Total free lipids from MDR strain of Mycobacterium tuberculosis “M” reduce T cell activation and CTL activity in healthy individuals
- Polymorphisms of 20 regulatory proteins between Mycobacterium tuberculosis and Mycobacterium bovis